NCT06229873

Brief Summary

This clinical trial aims to assess the efficacy of inspiratory muscle strength training (IMST) guided by a smartphone app vs. IMST delivered in a clinical research setting for lowering systolic blood pressure in adults 18 years and older with elevated blood pressure. Participants will perform IMST for 5 minutes a day, 6 days a week, for 6 weeks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 16, 2024

Completed
13 days until next milestone

First Posted

Study publicly available on registry

January 29, 2024

Completed
5 months until next milestone

Study Start

First participant enrolled

July 11, 2024

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

March 6, 2026

Status Verified

March 1, 2026

Enrollment Period

1.5 years

First QC Date

January 16, 2024

Last Update Submit

March 4, 2026

Conditions

Keywords

Inspiratory Muscle Strength TrainingAbove-normal blood pressureSmartphone ApplicationHypertension

Outcome Measures

Primary Outcomes (2)

  • Change from baseline in casual systolic blood pressure

    Systolic blood pressure at rest in the clinic setting

    6 weeks

  • Change from baseline in home systolic blood pressure

    Systolic blood pressure measured at rest in the home

    6 weeks

Secondary Outcomes (3)

  • Change from baseline in endothelial function

    6 weeks

  • Change from baseline in maximum inspiratory pressure

    6 weeks

  • Difference in adherence to IMST

    6 weeks

Study Arms (2)

App-Based Inspiratory Muscle Strength Training

EXPERIMENTAL

Using a handheld device, participants will perform 30 breaths a day, six days a week, for six weeks. Training will be guided by a smartphone application.

Device: App-Based Inspiratory Muscle Strength Training

Clinic-Based Inspiratory Muscle Strength Training

ACTIVE COMPARATOR

Using a handheld device, participants will perform 30 breaths a day, six days a week, for six weeks. Training will be guided by researchers.

Device: Clinic-Based Inspiratory Muscle Strength Training

Interventions

Participants will perform inspiratory muscle strength training guided by a smartphone application. Participants will perform 30 breaths a day at 75% of maximal inspiratory pressure, 6 days a week, for 6 weeks. All training sessions will be guided by the smartphone application.

App-Based Inspiratory Muscle Strength Training

Participants will perform inspiratory muscle strength training guided by researchers. Participants will perform 30 breaths a day at 75% of maximal inspiratory pressure, 6 days a week, for 6 weeks. One training session each week will be performed in the research clinic.

Clinic-Based Inspiratory Muscle Strength Training

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18+ years
  • Ability to provide informed consent
  • Willing to accept random assignment to condition
  • Systolic blood pressure 120-160 mmHg
  • Owns an Apple or Android smartphone
  • Body mass index \<40 kg/m2
  • Subject report of being weight stable in the prior 3 months (\<2 kg weight change) and willing to remain weight stable during the 6-week intervention period
  • If woman of childbearing age:
  • Not pregnant (defined as self-report of pregnancy)
  • Willing to be abstinent or use approved contraception (i.e., hormonal contraception, intrauterine devices, barrier methods such as condoms with spermicide, and surgical sterilization) throughout the duration of the study

You may not qualify if:

  • Age \<18 years
  • Participant report of a chronic overt medical condition (e.g., unstable cardiovascular disease, recent myocardial infarction or stroke, cancer) that may make it unsafe to participate in the study under the discretion of the study Medical Director.
  • Inability to abstain from consumption of alcohol for 12 hours on experimental days.
  • Report of blood donation within 8 weeks prior to enrolling in the study or unwillingness to abstain from donating blood for 8 weeks after completing the study
  • Participant report of current ruptured eardrum or any other current condition of the ear
  • Participant report of recent abdominal surgery (past 3 months) or current abdominal hernia
  • Participant report of current asthma with very low symptom perception, frequent and severe exacerbations, or abnormally low perception of dyspnea
  • Participant report of past or current costochondritis (inflammation of the cartilage that joins the ribs to the breastbone)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Colorado Boulder

Boulder, Colorado, 80309, United States

Location

MeSH Terms

Conditions

Treatment Adherence and ComplianceHypertension

Condition Hierarchy (Ancestors)

Health BehaviorBehaviorVascular DiseasesCardiovascular Diseases

Study Officials

  • Daniel H Craighead, PhD

    University of Colorado, Boulder

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Parallel Assignment
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Distinguished Professor

Study Record Dates

First Submitted

January 16, 2024

First Posted

January 29, 2024

Study Start

July 11, 2024

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

March 6, 2026

Record last verified: 2026-03

Locations